Published in Mol Cell Biol on September 01, 1990
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J (1994) 3.58
c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J (1994) 3.01
Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J (1996) 2.86
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev (1998) 2.27
Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07
myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol (1998) 1.77
Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol (1993) 1.77
Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc Natl Acad Sci U S A (1995) 1.43
The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol Cell Biol (1997) 1.33
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med (2010) 1.15
Transcriptional suppression of cellular gene expression by c-Myc. Mol Cell Biol (1991) 1.14
The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol Cell Biol (1995) 1.14
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest (1994) 1.14
Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol Cell Biol (2000) 1.08
Myc: the beauty and the beast. Genes Cancer (2010) 1.07
Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein. Mol Biol Cell (1994) 1.04
MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Res (2012) 1.04
Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci U S A (1994) 1.03
Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol Cell Biol (1993) 1.00
Analysis of early events in acetylcholine receptor assembly. J Cell Biol (1991) 0.98
Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages. J Virol (1992) 0.87
MYC association with cancer risk and a new model of MYC-mediated repression. Cold Spring Harb Perspect Med (2014) 0.79
Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus. J Virol (1996) 0.78
Defective Hfp-dependent transcriptional repression of dMYC is fundamental to tissue overgrowth in Drosophila XPB models. Nat Commun (2015) 0.77
MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation. Cell Cycle (2016) 0.75
Extracellular synaptic factors induce clustering of acetylcholine receptors stably expressed in fibroblasts. J Cell Biol (1991) 0.75
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (1988) 27.01
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (1983) 8.18
Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol (1987) 5.67
Expression of human class II major histocompatibility complex antigens using retrovirus vectors. Proc Natl Acad Sci U S A (1987) 4.84
Identification of the human c-myc protein nuclear translocation signal. Mol Cell Biol (1988) 3.30
Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein. Nature (1989) 2.70
Negative autoregulation of c-myc transcription. EMBO J (1990) 2.38
Structure and expression of the murine L-myc gene. EMBO J (1987) 1.64
DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences. EMBO J (1989) 1.60
IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J (1989) 1.42
Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins. J Virol (1986) 1.39
A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res (1987) 1.33
Negative regulation of c-myc transcription involves myc family proteins. Oncogene Res (1988) 1.27
Structure of mutant and wild-type MC29 v-myc alleles and biochemical properties of their protein products. Oncogene (1987) 1.04
Immunological probes in the analysis of myc protein expression. Curr Top Microbiol Immunol (1988) 0.84
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol (2000) 9.87
5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency. Nucleic Acids Res (1981) 8.10
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell (1996) 7.45
Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (1993) 7.20
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (1992) 5.50
Inhibition of telomerase limits the growth of human cancer cells. Nat Med (1999) 4.96
A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res (1990) 4.79
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature (2006) 4.57
Acetaminophen toxicity in an urban county hospital. N Engl J Med (1997) 4.26
Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell (1993) 4.10
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J (1994) 3.58
Induction of apoptosis by the Bcl-2 homologue Bak. Nature (1995) 3.56
Interaction between the origin recognition complex and the replication licensing system in Xenopus. Cell (1996) 3.45
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (1992) 3.43
Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res (1996) 3.37
The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A (1984) 3.31
Identification of the human c-myc protein nuclear translocation signal. Mol Cell Biol (1988) 3.30
Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J (1986) 3.07
Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol (1997) 3.03
Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by chicken c-myb gene. Cell (1984) 2.98
Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell (1985) 2.95
High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol (1997) 2.89
Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem (1989) 2.89
Max: functional domains and interaction with c-Myc. Genes Dev (1992) 2.88
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol (1986) 2.86
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature (1995) 2.79
Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg (1999) 2.79
Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein. Nature (1989) 2.70
c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell (1985) 2.69
Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol (1999) 2.65
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
An in situ transgenic enzyme marker for the midgestation mouse embryo and the visualization of inner cell mass clones during early organogenesis. Development (1989) 2.55
Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A (1993) 2.55
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature (1982) 2.54
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science (1997) 2.52
Isolation of monoclonal antibodies specific for products of avian oncogene myb. Mol Cell Biol (1984) 2.50
Multiple mRNAs are generated from the chicken lysozyme gene. Cell (1981) 2.46
The Drosophila caspase DRONC is regulated by DIAP1. EMBO J (2000) 2.46
Fungal infections in patients with acute leukemia. Am J Med (1982) 2.43
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell (1989) 2.42
Negative autoregulation of c-myc transcription. EMBO J (1990) 2.38
Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J (1999) 2.31
Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev (1994) 2.29
Thermal response of rat fibroblasts stably transfected with the human 70-kDa heat shock protein-encoding gene. Proc Natl Acad Sci U S A (1991) 2.26
Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation. Ann Intern Med (1989) 2.24
TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol (2001) 2.22
The role of c-myc in cell growth. Curr Opin Genet Dev (1993) 2.17
Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res (2001) 2.07
An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J Cell Biol (1996) 2.06
Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest (1995) 2.02
Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci U S A (1986) 2.00
A monoclonal anti-HLA antibody recognizes a mouse tumor-associated antigen. Eur J Immunol (1983) 1.97
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci U S A (2000) 1.97
Oncogenes and cell death. Curr Opin Genet Dev (1994) 1.97
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J Virol (1993) 1.90
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A (1990) 1.89
Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev (1997) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J (1989) 1.84
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol (1985) 1.84
The structure of human rhinovirus 16. Structure (1993) 1.83
Cloning of chicken lysozyme structural gene sequences synthesized in vitro. Nucleic Acids Res (1978) 1.80
Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J (1988) 1.80
Relationship between sonographic and pathologic findings in epidermal inclusion cysts. J Clin Ultrasound (2001) 1.77
Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene (1992) 1.73
c-myc protein expression in untransformed fibroblasts. Oncogene (1991) 1.72
Exposure and immunity to hepatitis-B virus in a liver unit. Lancet (1974) 1.68
Regulation of acetyl-CoA carboxylase. Biochem Soc Trans (2006) 1.64
Identification of a Drosophila melanogaster ICE/CED-3-related protease, drICE. EMBO J (1997) 1.61
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Heat shock protein hsp70 protects cells from thermal stress even after deletion of its ATP-binding domain. Proc Natl Acad Sci U S A (1992) 1.54
Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res (1993) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life (2000) 1.50